Sex-related disparities in outcomes of survival in biliary tract cancer patients

Authors: Nadiye Sever, Emil Yunusov, Nargiz Majidova, Erkam Kocaaslan, Pınar Erel, Yeşim Ağyol, Ali Kaan Güren, Abdussamet Çelebi, Selver Işık, İbrahim Vedat Bayoğlu, Osman Köstek, Murat Sarı

Source: Journal of Cancer Research and Clinical Oncology, Vol 151, Iss 2, Pp 1-8 (2025)

Subject Terms: Biliary cancers, Survival, Gender, Chemotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1432-1335

Access URL: https://doaj.org/article/6afd2571b38d48658ea1fe66a7113ec4

Impact of renin angiotensin system inhibitors on survival of patients with metastatic non-small cell lung cancer

Authors: Nadiye Sever, Emil Yunusov, Abdussamet Çelebi, Alper Yaşar, Nargiz Majidova, Erkam Kocaaslan, Pınar Erel, Yeşim Ağyol, Ali Kaan Güren, Selver Işık, Rukiye Arıkan, Özlem Ercelep, Osman Köstek, İbrahim Vedat Bayoğlu, Murat Sarıc

Source: Annals of Saudi Medicine, Vol 45, Iss 1, Pp 18-24 (2025)

Subject Terms: Medicine

File Description: electronic resource

Relation: https://doaj.org/toc/0256-4947; https://doaj.org/toc/0975-4466

Access URL: https://doaj.org/article/0961251a83a048ed9e478bf0ea481c27

Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study

Authors: Nargiz Majidova, Hacı Arak, Faruk Recep Ozalp, Onur Bas, Gulhan Ozcelik Koker, Erkan Buket Ozmarasalı, Yasemin Sagdıc Karateke, Teoman Sakalar, Sendag Yaslikaya, Ilknur Deliktas Onur, Goncagul Akdag, Ali Ogul, Murad Guliyev, Elif Sahin, Ebru Engin Delipoyraz, Ali Alkan, Okan Aydın, Nurullah Ilhan, Ozkan Alan, Sinem Akbas, Yaprak Cağlar, Ali Kaan Guren, Nadiye Sever, Halil Ibrahim Ellez, Fatih Selcukbiricik, Mustafa Muhammed Atcı, Ahmet Bilici, Nebi Serkan Demirci, Tugba Basoglu, Cengiz Karacin, Ismail Oguz Kara, Bulent Yıldız, Turkkan Evrensel, Mustafa Karaca, Omer Dizdar, Elif Atag, Alpaslan Ozgun, Osman Kostek

Source: Scientific Reports, Vol 15, Iss 1, Pp 1-8 (2025)

Subject Terms: Adjuvant therapy, Dabrafenib plus trametinib, Chemotherapy, Immune checkpoint inhibitors, Melanoma, Survival outcomes, Medicine, Science

File Description: electronic resource

Relation: https://doaj.org/toc/2045-2322

Access URL: https://doaj.org/article/9828f0522bfd4c938176e3ac69348cb2

Bevacizumab versus aflibercept with FOLFIRI after FOLFOX and bevacizumab in RAS mutant metastatic colon cancer a Turkish oncology group study

Authors: Serhat Sekmek, Sema Nur Ozsan Çelebi, Dogan Bayram, Cihan Erol, Fahriye Tugba Kos, Mehmet Ali Nahit Sendur, Yunus Emre Altıntas, Tugba Tuylu, Sedat Yildirim, Sedat Biter, Mehmet Mutlu Kıdı, Ertugrul Bayram, Nargiz Majidova, Ibrahim Vedat Bayoglu, Mehmetcan Atak, Kadriye Baskurt, Sinem Akbas, Ali Alkan, Ayberk Bayramgil, Ferit Aslan, Elif Sahin, Onur Yazdan Balcik, Ahmet Ziya Bayhan, Seray Saray, Erkan Arpaci, Yakup Ergun

Source: Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)

Subject Terms: Metastatic colon cancer, Aflibercept, Bevacizumab, Real-life data, Medicine, Science

File Description: electronic resource

Relation: https://doaj.org/toc/2045-2322

Access URL: https://doaj.org/article/b37a215f01c6451b946652f120eabbc8

Efficacy and Clinical Outcomes of Crizotinib in Patients with ROS1-Rearranged NSCLC: A Multicenter Study

Authors: Alper Topal, Goncagul Akdag, Sedat Yildirim, Oguzcan Kinikoglu, Deniz Isik, Gizem Yildirim, Salih Tunbekici, Fatih Kus, Aydın Acarbay, Murad Guliyev, Nargiz Majidova, Yasin Kutlu, Mustafa Erman, Hatice Odabas, Nedim Turan, Nuri Karadurmus

Source: Medicina, Vol 61, Iss 3, p 490 (2025)

Subject Terms: ROS1, lung cancer, crizotinib, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.mdpi.com/1648-9144/61/3/490; https://doaj.org/toc/1010-660X; https://doaj.org/toc/1648-9144

Access URL: https://doaj.org/article/b43b14acd3404ea29fba10ebc5c5f9b8

Which factors help to determine the long-term response to first-line tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma: A Turkish multi-centre study

Authors: Nargiz Majidova, Mustafa Seyyar, Demet Işık Bayraktar, Gülhan Dinç, Elfag İsgandarov, Javid Huseynov, Alper Yaşar, Abdussamet Çelebi, Nadiye Sever, Erkam Kocaaslan, Pınar Erel, Yeşim Ağyol, Ali Kaan Güren, Rukiye Arıkan, Selver Işık, Özlem Ercelep, Güzin Demirağ, Umut Kefeli, Osman Köstek, İbrahim Vedat Bayoğlu, Murat Sarı

Source: Biomolecules & Biomedicine (2024)

Subject Terms: International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) score, renal cell carcinoma (RCC), rosine kinase inhibitor (TKI), long-lasting response, Biology (General), QH301-705.5

File Description: electronic resource

Relation: https://www.bjbms.org/ojs/index.php/bjbms/article/view/10512; https://doaj.org/toc/2831-0896; https://doaj.org/toc/2831-090X

Access URL: https://doaj.org/article/6efa41f2967843798260bb7a256b080e